The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
150 - 210 jobs Number of planned job losses
Announcement Date
10 March 2003
Employment effect (start)
Foreseen end date
Description
Organon has developed innovative prescription medicines for gynecology, mental health, anesthesia, and for cardiovascular diseases. The company currently employs around 13,000 people in more than 50 countries. Worlwide, Akzo Nobel decided to suppress some 500 jobs. The management will use early retirements and other ways to avoid direct dismissals. In April 2003, 60 more jobs suppressed in Oss.
Sources
2 April 2003: De Financiële Telegraaf
Citation
Eurofound (2003), Organon NV, Internal restructuring in Netherlands, factsheet number 58840, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/58840.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
